Global Estrogen Receptor Modulators Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Estrogen Receptor Modulators Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Estrogen receptor modulators are a type of pharmacological agent that blocks the estrogen's function in the tissues by binding to estrogen receptors located at numerous tissues. It is either act as agonists or antagonists in diverse tissues and is widely used in the treatment of breast cancer and post-menopausal osteoporosis.It is of great importance to the healthcare sector
Estrogen Receptor Modulators report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Estrogen Receptor Modulators market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Breast Cancer and Postmenopausal Osteoporosis are the major drivers for the industry.
The International Osteoporosis Foundation estimates that 75 million people in Europe, the United States and Japan have osteoporosis. Osteoporosis is characterized by low bone mass and structural deterioration of bone tissue, leading to an increased risk of fractures. SERMs are effective in controlling and preventing osteoporosis, especially in postmenopausal women. With aging population and increasing prevalence of osteoporosis, demand for SERMs as an effective treatment option is expected to increase, thereby driving the global selective estrogen receptor modulators market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Estrogen Receptor Modulators market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
F. Hoffmann-La Roche Ltd
Mylan NV
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
Bayer AG
Lilly
Merck & Co., Inc
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Alkem Labs Ltd
Apotex Inc
Kyowa Kirin Co., Ltd
Segment by Type
Breast Cancer
Vaginitis
Osteoporosis
Other
Breast Cancer
Postmenopausal Osteoporosis
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Estrogen Receptor Modulators market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Estrogen Receptor Modulators, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Estrogen Receptor Modulators industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Estrogen Receptor Modulators in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Estrogen Receptor Modulators introduction, etc. Estrogen Receptor Modulators Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Estrogen Receptor Modulators market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Estrogen Receptor Modulators report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Estrogen Receptor Modulators market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Breast Cancer and Postmenopausal Osteoporosis are the major drivers for the industry.
The International Osteoporosis Foundation estimates that 75 million people in Europe, the United States and Japan have osteoporosis. Osteoporosis is characterized by low bone mass and structural deterioration of bone tissue, leading to an increased risk of fractures. SERMs are effective in controlling and preventing osteoporosis, especially in postmenopausal women. With aging population and increasing prevalence of osteoporosis, demand for SERMs as an effective treatment option is expected to increase, thereby driving the global selective estrogen receptor modulators market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Estrogen Receptor Modulators market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
F. Hoffmann-La Roche Ltd
Mylan NV
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
Bayer AG
Lilly
Merck & Co., Inc
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Alkem Labs Ltd
Apotex Inc
Kyowa Kirin Co., Ltd
Segment by Type
Breast Cancer
Vaginitis
Osteoporosis
Other
Segment by Application
Breast Cancer
Postmenopausal Osteoporosis
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Estrogen Receptor Modulators market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Estrogen Receptor Modulators, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Estrogen Receptor Modulators industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Estrogen Receptor Modulators in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Estrogen Receptor Modulators introduction, etc. Estrogen Receptor Modulators Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Estrogen Receptor Modulators market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices